Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
40.17
-0.53 (-1.30%)
At close: Dec 5, 2025, 4:00 PM EST
40.22
+0.05 (0.12%)
After-hours: Dec 5, 2025, 5:01 PM EST
Pro-Dex Market Cap
Pro-Dex has a market cap or net worth of $131.20 million as of December 5, 2025. Its market cap has decreased by -4.10% in one year.
Market Cap
131.20M
Enterprise Value
134.80M
1-Year Change
-4.10%
Ranking
Category
Stock Price
$40.17
Market Cap Chart
Since December 1, 1998, Pro-Dex's market cap has increased from $18.70M to $131.20M, an increase of 601.59%. That is a compound annual growth rate of 7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 132.80M | -12.86% |
| Dec 31, 2024 | 152.40M | 145.41% |
| Dec 29, 2023 | 62.10M | 9.14% |
| Dec 30, 2022 | 56.90M | -33.06% |
| Dec 31, 2021 | 85.00M | -28.87% |
| Dec 31, 2020 | 119.50M | 71.45% |
| Dec 31, 2019 | 69.70M | 36.40% |
| Dec 31, 2018 | 51.10M | 72.05% |
| Dec 29, 2017 | 29.70M | 55.50% |
| Dec 30, 2016 | 19.10M | 91.00% |
| Dec 31, 2015 | 10.00M | -2.91% |
| Dec 31, 2014 | 10.30M | 27.16% |
| Dec 31, 2013 | 8.10M | 19.12% |
| Dec 31, 2012 | 6.80M | -16.05% |
| Dec 30, 2011 | 8.10M | 24.62% |
| Dec 31, 2010 | 6.50M | 32.65% |
| Dec 31, 2009 | 4.90M | 16.67% |
| Dec 31, 2008 | 4.20M | -70.21% |
| Dec 31, 2007 | 14.10M | 2.17% |
| Dec 29, 2006 | 13.80M | -40.77% |
| Dec 30, 2005 | 23.30M | -6.43% |
| Dec 31, 2004 | 24.90M | -9.78% |
| Dec 31, 2003 | 27.60M | 590.00% |
| Dec 31, 2002 | 4.00M | -44.44% |
| Dec 31, 2001 | 7.20M | -71.54% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |